Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gooley

Showing results (651-660 of 956) with videos related to

Pageof 96
Sort By:
Haematologica|October 30, 2020
Use of the HLA-B leader to optimize cord blood transplantationEffie W Petersdorf, Ted Gooley, Fernanda Volt, et al.
Leukemia & Lymphoma|May 3, 2008
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphomaBrian G Till, Theodore A Gooley, Nathan Crawford, et al.
Frontiers in Oncology|June 1, 2023
Acute kidney injury and chronic kidney disease in umbilical cord blood transplant recipientsPaolo Lopedote, Elisabetta Xue, Julie Chotivatanapong, et al.
British Journal of Haematology|May 29, 2010
Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomasAndrei R Shustov, Theodore A Gooley, Brenda M Sandmaier, et al.
Transplantation and Cellular Therapy|May 20, 2024
Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive ChemomobilizationAndrew J Portuguese, Albert C Yeh, Rahul Banerjee, et al.
The New England Journal of Medicine|November 20, 2014
Donor activating KIR2DS1 in leukemiaJeffrey M Venstrom, Bo Dupont, Katharine C Hsu, et al.
Journal of Chromatography. A|September 20, 2021
Small footprint liquid chromatography-mass spectrometry for pharmaceutical reaction monitoring and automated process analysisMohamed Hemida, Paul R Haddad, Shing C Lam, et al.
Blood Cancer Journal|May 14, 2016
A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myelomaP S Becker, T A Gooley, D J Green, et al.
Journal for Immunotherapy of Cancer|November 9, 2024
Magnitude of antigen-specific T-cell immunity the month after completing vaccination series predicts the development of long-term persistence of antitumor immune responseJohn B Liao, James Y Dai, Jessica L Reichow, et al.
Blood|September 8, 2005
Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantationLuisa Giaccone, Jeannine S McCune, Michael B Maris, et al.
Pageof 96

Showing results (651-660 of 956) with videos related to

Sort By:
Pageof 96
Haematologica|October 30, 2020
Use of the HLA-B leader to optimize cord blood transplantationEffie W Petersdorf, Ted Gooley, Fernanda Volt, et al.
Leukemia & Lymphoma|May 3, 2008
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphomaBrian G Till, Theodore A Gooley, Nathan Crawford, et al.
Frontiers in Oncology|June 1, 2023
Acute kidney injury and chronic kidney disease in umbilical cord blood transplant recipientsPaolo Lopedote, Elisabetta Xue, Julie Chotivatanapong, et al.
British Journal of Haematology|May 29, 2010
Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomasAndrei R Shustov, Theodore A Gooley, Brenda M Sandmaier, et al.
Transplantation and Cellular Therapy|May 20, 2024
Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive ChemomobilizationAndrew J Portuguese, Albert C Yeh, Rahul Banerjee, et al.
The New England Journal of Medicine|November 20, 2014
Donor activating KIR2DS1 in leukemiaJeffrey M Venstrom, Bo Dupont, Katharine C Hsu, et al.
Journal of Chromatography. A|September 20, 2021
Small footprint liquid chromatography-mass spectrometry for pharmaceutical reaction monitoring and automated process analysisMohamed Hemida, Paul R Haddad, Shing C Lam, et al.
Blood Cancer Journal|May 14, 2016
A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myelomaP S Becker, T A Gooley, D J Green, et al.
Journal for Immunotherapy of Cancer|November 9, 2024
Magnitude of antigen-specific T-cell immunity the month after completing vaccination series predicts the development of long-term persistence of antitumor immune responseJohn B Liao, James Y Dai, Jessica L Reichow, et al.
Blood|September 8, 2005
Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantationLuisa Giaccone, Jeannine S McCune, Michael B Maris, et al.
Pageof 96